Guwahati: In a groundbreaking development, the Indian Institute of Technology Guwahati has successfully transferred pioneering vaccine technology to BioMed Pvt. Ltd. This technology marks a milestone in India’s vaccine landscape, offering a solution to combat the classical swine fever virus in pigs and wild boars.
The first-of-its-kind recombinant vector vaccine for pigs, developed through a reverse genetic platform at IIT Guwahati, promises to address the severe threat posed by swine fever. Although not transmissible to humans, swine fever has a high mortality rate among pigs and has been a persistent challenge in India, particularly in northeastern states and regions like Bihar, Kerala, Punjab, Haryana, and Gujarat.
Initiated in 2018-2019 through collaborative efforts between researchers from the Department of Biosciences and Bioengineering at IIT Guwahati and Assam Agricultural University, the vaccine development has culminated in significant research findings published in journals such as Process Biochemistry and Archives of Virology.
...
Trending Stories
- Why experts are working on an anti snake venom designed for Northeast
- Monkey Man: Pulsating action undermined by overt political bias
- Nagaland Chamber of Commerce calls for stocking window amid shutdown
- NFR undertakes track restoration in Lumding -Badarpur hill section
- Analysis: How Sikkim Budget hurt state’s marginalised population
- When war is no deterrent to a desperate job-seeker
